These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29100367)

  • 1. Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer.
    Xu YF; Hannafon BN; Zhao YD; Postier RG; Ding WQ
    Oncotarget; 2017 Sep; 8(44):77028-77040. PubMed ID: 29100367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
    Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.
    Aso T; Ohtsuka T; Tamura K; Ideno N; Kono H; Nagayoshi Y; Ohuchida K; Ueda J; Takahata S; Shindo K; Aishima S; Oda Y; Mizumoto K; Tanaka M
    Pancreas; 2014 Apr; 43(3):361-6. PubMed ID: 24622064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively.
    Yu Q; Xu C; Yuan W; Wang C; Zhao P; Chen L; Ma J
    Biomed Res Int; 2017; 2017():6495867. PubMed ID: 28466015
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.
    Li Z; Tao Y; Wang X; Jiang P; Li J; Peng M; Zhang X; Chen K; Liu H; Zhen P; Zhu J; Liu X; Liu X
    Cell Physiol Biochem; 2018; 51(2):610-629. PubMed ID: 30458449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs.
    Xu YF; Xu X; Bhandari K; Gin A; Rao CV; Morris KT; Hannafon BN; Ding WQ
    PLoS One; 2021; 16(11):e0259563. PubMed ID: 34784377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma.
    Yoshizawa N; Sugimoto K; Tameda M; Inagaki Y; Ikejiri M; Inoue H; Usui M; Ito M; Takei Y
    Oncol Lett; 2020 Apr; 19(4):2677-2684. PubMed ID: 32218818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis.
    Kong X; Du Y; Wang G; Gao J; Gong Y; Li L; Zhang Z; Zhu J; Jing Q; Qin Y; Li Z
    Dig Dis Sci; 2011 Feb; 56(2):602-9. PubMed ID: 20614181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
    Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
    Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
    Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
    J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRSF1 regulates exosome microRNA enrichment in human cancer cells.
    Xu YF; Xu X; Gin A; Nshimiyimana JD; Mooers BHM; Caputi M; Hannafon BN; Ding WQ
    Cell Commun Signal; 2020 Aug; 18(1):130. PubMed ID: 32819370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions.
    Hernandez YG; Lucas AL
    World J Gastrointest Oncol; 2016 Jan; 8(1):18-29. PubMed ID: 26798434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer.
    Yan S; Han B; Gao S; Wang X; Wang Z; Wang F; Zhang J; Xu D; Sun B
    Oncotarget; 2017 Sep; 8(36):60149-60158. PubMed ID: 28947960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People.
    Tian F; Shen Y; Chen Z; Li R; Ge Q
    Biomed Res Int; 2017; 2017():1304816. PubMed ID: 28656135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That Are Maintained in Pancreatic Ductal Adenocarcinoma.
    Fernandez-Castañer E; Vila-Casadesus M; Vila-Navarro E; Parra C; Lozano JJ; Castells A; Gironella M
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer.
    Liu J; Gao J; Du Y; Li Z; Ren Y; Gu J; Wang X; Gong Y; Wang W; Kong X
    Int J Cancer; 2012 Aug; 131(3):683-91. PubMed ID: 21913185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.
    Goto T; Fujiya M; Konishi H; Sasajima J; Fujibayashi S; Hayashi A; Utsumi T; Sato H; Iwama T; Ijiri M; Sakatani A; Tanaka K; Nomura Y; Ueno N; Kashima S; Moriichi K; Mizukami Y; Kohgo Y; Okumura T
    BMC Cancer; 2018 Jan; 18(1):116. PubMed ID: 29385987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Exosome-Derived microRNAs as Potential Diagnostic and Prognostic Biomarkers in Brazilian Pancreatic Cancer Patients.
    Marin AM; Mattar SB; Amatuzzi RF; Chammas R; Uno M; Zanette DL; Aoki MN
    Biomolecules; 2022 May; 12(6):. PubMed ID: 35740894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.
    Vila-Navarro E; Vila-Casadesús M; Moreira L; Duran-Sanchon S; Sinha R; Ginés À; Fernández-Esparrach G; Miquel R; Cuatrecasas M; Castells A; Lozano JJ; Gironella M
    Ann Surg; 2017 Jun; 265(6):1226-1234. PubMed ID: 27232245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.